Cargando…
Clinical impact of splicing in neurodevelopmental disorders
Clinical exome sequencing is frequently used to identify gene-disrupting variants in individuals with neurodevelopmental disorders. While splice-disrupting variants are known to contribute to these disorders, clinical interpretation of cryptic splice variants outside of the canonical splice site has...
Autores principales: | Sanders, Stephan J., Schwartz, Grace B., Farh, Kyle Kai-How |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183108/ https://www.ncbi.nlm.nih.gov/pubmed/32331533 http://dx.doi.org/10.1186/s13073-020-00737-2 |
Ejemplares similares
-
Predicting neurodevelopmental outcome in children born very preterm – does neonatal MRI have a role?
por: Anderson, Peter J.
Publicado: (2023) -
The problem of selection bias in studies of pre-mRNA splicing
por: Dwyer, Zachary W., et al.
Publicado: (2023) -
The hidden burden of eating disorders during the COVID-19 pandemic
por: Zipfel, Stephan, et al.
Publicado: (2022) -
The economic impact of eating disorders in children and youth in Canada: a call to action to improve youth eating disorder research and care
por: Coelho, Jennifer S., et al.
Publicado: (2023) -
Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders
por: Hoang, Ny, et al.
Publicado: (2018)